Genmab — Juni 2019
-
guidning
-
vi skal ihvertfald ikke have vilde Q3 rabatter, så holder den ikke
-
jeg tror også den kan nås, men at sige at jan er mega konservativ og går med livrem og seler, det er ret langt fra sandheden
-
Det er ganske givet ikke 25% royalties men 25% af provenuet på stoffet. Så fra oms skal trækkes produktions salg og distributions udgifter. Så nok 15-19%
-
from Nature Reviews Drug Discovery : Bispecific antibodies: a mechanistic review of the pipeline- https://www.nature.com/articles/s41573-019-0028-1
full article https://sci-hub.tw/https://www.nature.com/articles/s41573-019-0028-1 -
try full article again - https://sci-hub.tw/https://www.nature.com/articles/s41573-019-0028-1
-
In this video, Dr. Brian G.M. Durie provides details of the CASSIOPEIA trial. https://www.youtube.com/watch?v=NhuAkDVRAM4
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind